Status: current, Primitive. Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3788860017 | Upadacitinib (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3788861018 | Upadacitinib | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Upadacitinib | Is a | Heterocyclic compound | true | Inferred relationship | Some | ||
| Upadacitinib | Is a | Janus kinase inhibitor | true | Inferred relationship | Some | ||
| Upadacitinib | Has disposition | Janus kinase inhibitor | true | Inferred relationship | Some | ||
| Upadacitinib | Is a | Immunosuppressant | true | Inferred relationship | Some | ||
| Upadacitinib | Has disposition | Immunomodulator | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Upadacitinib-containing product | Has active ingredient | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib only product | Has active ingredient | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib-containing product in oral dose form | Has active ingredient | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib only product in oral dose form | Has active ingredient | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib 15 mg prolonged-release oral tablet | Has BoSS | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib 15 mg prolonged-release oral tablet | Has precise active ingredient | True | Upadacitinib | Inferred relationship | Some | 1 |
| Upadacitinib hemihydrate | Is modification of | True | Upadacitinib | Inferred relationship | Some |
Reference Sets
Substance foundation reference set
Description inactivation indicator reference set
FHIR